Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus.

Hollande C, Mallet V, Darbeda S, Vallet-Pichard A, Fontaine H, Verkarre V, Sogni P, Terris B, Gouya H, Pol S.

Medicine (Baltimore). 2016 Mar;95(11):e3081. doi: 10.1097/MD.0000000000003081.

2.

Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching.

Kim MJ, Kim SW, Chang HH, Kim Y, Jin S, Jung H, Park JH, Kim S, Lee JM.

Infect Chemother. 2015 Dec;47(4):231-8. doi: 10.3947/ic.2015.47.4.231. Epub 2015 Dec 30.

3.

HAART toxicity masquerading as a surgical abdomen.

Feghali A, Wang Y, Irizarry E, Lueders M.

Int J Surg Case Rep. 2016;18:33-6. doi: 10.1016/j.ijscr.2015.11.028. Epub 2015 Dec 3.

4.

Effects of a 2-Year Supervised Exercise Program Upon the Body Composition and Muscular Performance of HIV-Infected Patients.

Paes Lda S, Borges JP, Dos Santos FM, de Oliveira TP, Dupin JG, Harris EA, Farinatti P.

Open AIDS J. 2015 Oct 20;9:80-8. doi: 10.2174/1874613601509010080. eCollection 2015.

5.

The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma.

Renga B, Francisci D, Carino A, Marchianò S, Cipriani S, Chiara Monti M, Del Sordo R, Schiaroli E, Distrutti E, Baldelli F, Fiorucci S.

Sci Rep. 2015 Oct 15;5:15403. doi: 10.1038/srep15403.

6.

A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome.

Kaiser JD.

Int J Clin Exp Med. 2015 Jul 15;8(7):11064-74. eCollection 2015.

7.

Economic impact of HIV/AIDS: a systematic review in five European countries.

Trapero-Bertran M, Oliva-Moreno J.

Health Econ Rev. 2014 Dec;4(1):15. doi: 10.1186/s13561-014-0015-5. Epub 2014 Sep 16.

8.

Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.

Pery E, Sheehy A, Miranda Nebane N, Misra V, Mankowski MK, Rasmussen L, Lucile White E, Ptak RG, Gabuzda D.

Virology. 2015 Oct;484:276-87. doi: 10.1016/j.virol.2015.06.014. Epub 2015 Jul 1.

PMID:
26141568
9.

Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity.

de Boer R, Smith RL, De Vos WH, Manders EM, Brul S, van der Spek H.

PLoS One. 2015 May 13;10(5):e0126220. doi: 10.1371/journal.pone.0126220. eCollection 2015.

10.

Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model.

Molina PE, Amedee AM, Winsauer P, Nelson S, Bagby G, Simon L.

J Neuroimmune Pharmacol. 2015 Jun;10(2):217-32. doi: 10.1007/s11481-015-9599-8. Epub 2015 Mar 21. Review.

11.

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.

Huntington S, Thorne C, Newell ML, Anderson J, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study; UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2015 Apr 24;29(7):801-9. doi: 10.1097/QAD.0000000000000620.

12.

Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?

Sasson SC, Kelleher AD.

Clin Transl Immunology. 2014 Jul 11;3(7):e19. doi: 10.1038/cti.2014.12. eCollection 2014 Jul. Review.

13.

Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers.

Metzger IF, Quigg TC, Epstein N, Aregbe AO, Thong N, Callaghan JT, Flockhart DA, Nguyen AT, Stevens CK, Gupta SK, Desta Z.

Curr Ther Res Clin Exp. 2014 Sep 27;76:64-9. doi: 10.1016/j.curtheres.2014.05.002. eCollection 2014 Dec.

14.
15.

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects.

Cha YJ, Lim KS, Park MK, Schneider S, Bray B, Kang MC, Chung JY, Yoon SH, Cho JY, Yu KS.

Drug Des Devel Ther. 2014 Sep 26;8:1613-9. doi: 10.2147/DDDT.S65596. eCollection 2014.

16.

Morcellized Omental Transfer for Severe HIV Facial Wasting.

Teplica D, Bohorquez M, Podbielski FJ.

Plast Reconstr Surg Glob Open. 2013 Dec 6;1(8):e73. doi: 10.1097/GOX.0000000000000006. eCollection 2013 Nov.

17.

Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study.

Benea OE, Streinu-Cercel A, Dorobăţ C, Rugină S, Negruţiu L, Cupşa A, Duiculescu D, Chiriac C, Itu C, Prisăcariu LJ, Iosif I.

Germs. 2014 Sep 1;4(3):59-69. doi: 10.11599/germs.2014.1057. eCollection 2014 Sep.

18.

Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy.

Newville H, Roley J, Sorensen JL.

J Subst Abuse Treat. 2015 Jan;48(1):56-61. doi: 10.1016/j.jsat.2014.07.013. Epub 2014 Aug 6.

19.

Efavirenz induces neuronal autophagy and mitochondrial alterations.

Purnell PR, Fox HS.

J Pharmacol Exp Ther. 2014 Nov;351(2):250-8. doi: 10.1124/jpet.114.217869. Epub 2014 Aug 26.

20.

"What I got to go through": normalization and HIV-positive adolescents.

Philbin MM.

Med Anthropol. 2014;33(4):288-302. doi: 10.1080/01459740.2013.847436.

Items per page

Supplemental Content

Write to the Help Desk